JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 15 No. 5 343-348
© 1974 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henry, R. E.
Right arrow Articles by Donati, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henry, R. E.
Right arrow Articles by Donati, R. M.

Effect of Granulocytopenia, Marrow Suppressive Drugs, and Infection on Marrow Reticuloendothelial Patterns

Robert E. Henry, James W. Fletcher, Erica Solaric-George and Robert M. Donati

St. Louis Veterans Administration Hospital and St. Louis University School of Medicine, St. Louis, Missouri

Correspondence: For reprints contact: Robert E. Henry (172-JC), St. Louis VA Hospital, St. Louis, Mo. 63125.

ABSTRACT

RE marrow extension beyond the proximal one-third of the femur and humerus was observed in 19 of 38 studies performed on 26 patients with Hodgkin's disease or lymphoma. All of the patients demonstrating RE marrow extension had been treated with radiation, chemotherapy, or a combination of both. None of the untreated patients demonstrated RE marrow extension. A significant association with granulocytopenia was noted in patients with Hodgkin's disease or lymphoma demonstrating RE marrow extension. A similar association was seen in five additional patients with either renal transplant or metastatic carcinoma rendered granulocytopenic by immunosuppression or chemotherapy. Examination of an additional 13 patients with granulocytopenia not associated with chemotherapy did not reveal RE marrow extension. However, RE marrow extension in association with granulocytosis was observed in four of an additional seven patients with acute bacterial infection and no primary hematologic disease. Serial studies in patients with Hodgkin's disease or lymphoma revealed an association between the extending RE marrow pattern and intolerance to chemotherapy in three patients whereas three other patients without marrow extension tolerated chemotherapy well.

These data suggest that RE marrow extension following chemotherapy and radiation is due to compromised hematopoiesis reflected by granulocytopenia. The appearance of an extended RE marrow pattern following chemotherapy appears to be predictive of poor tolerance to further chemotherapy whereas nonextension of the RE marrow reflects adequate marrow granulopoietic reserve. Subclinical infection cannot be completely excluded as a cause of RE marrow extension in patients with chemotherapy-associated granulocytopenia.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1974 by the Society of Nuclear Medicine.